These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22100375)

  • 41. Relationship between aortic valve calcification and aortic atherosclerosis: a transoesophageal echocardiography study.
    Wysokiński A; Zapolski T
    Kardiol Pol; 2006 Jul; 64(7):694-701; discussion 702-3. PubMed ID: 16886126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary artery calcification correlates with the presence and severity of valve calcification.
    Koulaouzidis G; Nicoll R; MacArthur T; Jenkins PJ; Henein MY
    Int J Cardiol; 2013 Oct; 168(6):5263-6. PubMed ID: 23993324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ochronosis of Mitral Valve and Coronary Arteries.
    Gottschalk BH; Blankenstein J; Guo L
    Ann Thorac Surg; 2018 Jul; 106(1):e19-e20. PubMed ID: 29501639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Black aortic valve--ochronosis.
    Laco J; Steiner I; Kubicek V; Spacek J
    APMIS; 2008 Nov; 116(11):1011-2. PubMed ID: 19133000
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.
    Milan AM; Hughes AT; Davison AS; Devine J; Usher J; Curtis S; Khedr M; Gallagher JA; Ranganath LR
    Ann Clin Biochem; 2017 May; 54(3):323-330. PubMed ID: 28081634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
    Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkaptonuria presenting with ochronotic spondyloarthropathy.
    Al-Mahfoudh R; Clark S; Buxton N
    Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ochronotic involvement of the aortic and mitral valves in a 72-year-old man.
    Atalay A; Gocen U; Basturk Y; Kozanoglu E; Yaliniz H
    Tex Heart Inst J; 2015 Feb; 42(1):84-6. PubMed ID: 25873809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Preoperative Assessment of Significant Coronary Stenosis Based on a Semiquantitative Analysis of Coronary Artery Calcification on Noncontrast Computed Tomography in Aortic Stenosis Patients Undergoing Aortic Valve Replacement.
    Hwang JW; Kim SM; Park SJ; Cho EJ; Lee SC; Choe YH; Park SW
    Medicine (Baltimore); 2016 Mar; 95(9):e2906. PubMed ID: 26945385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Free radical mechanism of homogentisic acid in alkaptonuria].
    Gerasimov AM; Zakharov AS
    Vopr Med Khim; 1988; 34(1):112-5. PubMed ID: 2835867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Dark Side of the Heart: Cardiovascular Manifestation of Ochronosis.
    Planinc M; Unic D; Baric D; Blazekovic R; Sribar A; Sutlic Z; Rudez I
    Ann Thorac Surg; 2019 Oct; 108(4):e257-e259. PubMed ID: 30926473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
    Hughes JH; Liu K; Plagge A; Wilson PJM; Sutherland H; Norman BP; Hughes AT; Keenan CM; Milan AM; Sakai T; Ranganath LR; Gallagher JA; Bou-Gharios G
    Hum Mol Genet; 2019 Dec; 28(23):3928-3939. PubMed ID: 31600782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alkaptonuria.
    Grosicka A; Kucharz EJ
    Wiad Lek; 2009; 62(3):197-203. PubMed ID: 20229718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aortic valve ochronosis: a rare manifestation of alkaptonuria.
    Steger CM
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Black-Colored Ligamentum Flavum Due to Alkaptonuria.
    Yucetas SC; Ucler N
    J Neurol Surg A Cent Eur Neurosurg; 2019 Mar; 80(2):131-133. PubMed ID: 30477028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Alkaptonuria. A brief outline of present-day knowledge of the biochemical aspects of the metabolic defect and pathogenesis of the disease (author's transl)].
    Koska L; Srsen S
    Cas Lek Cesk; 1982 Jun; 121(22):673-6. PubMed ID: 7105116
    [No Abstract]   [Full Text] [Related]  

  • 57. Alkaptonuria caused by compound heterozygote mutations.
    Elçioğlu NH; Aytuğ AF; Müller CR; Gürbüz O; Ergun T; Kotiloğlu E; Elçioğlu M
    Genet Couns; 2003; 14(2):207-13. PubMed ID: 12872815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
    Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
    Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urine homogentisic acid and tyrosine: simultaneous analysis by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Christensen P; Ross G; Davison AS; Gallagher JA; Dutton JJ; Ranganath LR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():106-12. PubMed ID: 24952314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitral and aortic valve stenosis in alkaptonuria.
    Saito T; Numata Y; Yamanaka Y
    Asian Cardiovasc Thorac Ann; 2017 Mar; 25(3):239-240. PubMed ID: 26823449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.